Please ensure Javascript is enabled for purposes of website accessibility

3 Top Consumer Staples Stocks to Buy in 2017

By Demitri Kalogeropoulos - Apr 24, 2017 at 5:49PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Here are a few attractive buy candidates in this recession-proof sector.

Many investors are attracted to consumer staples stocks because these businesses tend to perform well regardless of broader market trends. After all, recessions devastate demand for expensive discretionary products like automobiles and homes. But consumers don't easily change their purchasing habits when it comes to their favorite toothpastes, shaving creams, and paper towels.

Below, we'll highlight a few important metrics to watch when evaluating consumer staples stocks and look at why Procter & Gamble (PG -0.71%), Johnson & Johnson (JNJ -2.07%), and Colgate-Palmolive (CL -1.05%) deserve a spot on your 2017 watch list.

Johnson & Johnson for diversity

Johnson & Johnson dominates a wide range of markets in the healthcare industry, which makes the blue chip titan a great choice for investors who value diversity. Its consumer staples segment is anchored by global brands like Listerine mouthwash, Neutrogena skin care products, and Tylenol painkillers.

A baby having its hair washed.

Image source: Getty Images.

That portfolio of franchises bounced along at near-zero growth in a weak overall market last quarter, but Johnson & Johnson still managed healthy overall gains thanks to contributions from its other main business lines, medical devices and pharmaceuticals.

To see why this stock has trounced peers over the long term, investors can simply check its dedication to innovation. Backed up by a $9 billion annual research and development budget, Johnson & Johnson directs more resources toward its pipeline of drugs and consumer products than almost any other company could hope to spend.

The healthcare giant expects to boost organic sales by 4% to 5% in 2017 while its earnings grow by as much as 8% to $7.27 per share. Toss in a hefty 2.6% dividend yield, and investors should be looking at double-digit total returns this year.

Procter & Gamble for turnaround hopes

Procter & Gamble owns many of the biggest consumer brands in the world, including Gillette, which dominates the market for razors and blades with an incredible 65% share. Yet that figure is down from 70% just a few years ago as P&G has struggled against rising competition both from cheaper in-store brands and from disruptive business models like Unilever's online-based Dollar Shave Club.

Investors buying the stock today have good reason to expect a brightening overall picture, though, given that P&G has posted two straight quarters of surprisingly strong sales growth paired with improving profitability.

Its new, more targeted product portfolio might be just what the company needs to get back to market-beating sales and earnings gains likely beginning in the back half of 2017 and into 2018. In the meantime, shareholders stand to benefit from one of the most generous cash return programs around -- including $22 billion of dividends and stock repurchases this year alone.

Colgate-Palmolive for profitability

Some investors may have written Colgate-Palmolive off following a fiscal 2016 that saw revenue decline 5%. However, look closer and you'll see a business that's as strong as it has ever been.

Organic sales, which strip out currency swings and exited business lines, jumped by 4% last year compared to 2% for Kimberly-Clark and 1% for P&G. Colgate also increased its dominant hold on the toothpaste industry, with global market share ticking up to 35.5% from 35.3%. Its U.S. lead rose by the same amount to an incredible 41.4% of the market.

The most impressive metric in Colgate's arsenal is profitability, though. Operating margin is well over 20% of sales to put the company at the top of its industry:

PG Operating Margin (TTM) Chart

PG Operating Margin (TTM) data by YCharts.

Different characteristics of each of these stocks may appeal to different types of investors. P&G's 3% dividend yield, for example, makes it especially attractive to income investors when compared to Colgate's 2.2% or Johnson & Johnson's 2.6%. On the other hand, growth fans would likely prefer Johnson & Johnson thanks to the boost it gets from pharmaceutical hits.

But all three companies have demonstrated that their businesses can navigate weak industry trends. In that way, they exemplify the best of the consumer staples sector: Steady, highly profitable revenue growth that helps fund continued market-share gains and increasing cash returns to investors.

Demitrios Kalogeropoulos has no position in any stocks mentioned. The Motley Fool owns shares of and recommends Johnson & Johnson. The Motley Fool recommends Kimberly-Clark and Unilever. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

The Procter & Gamble Company Stock Quote
The Procter & Gamble Company
PG
$145.26 (-0.71%) $-1.04
Johnson & Johnson Stock Quote
Johnson & Johnson
JNJ
$167.14 (-2.07%) $-3.53
Colgate-Palmolive Company Stock Quote
Colgate-Palmolive Company
CL
$79.50 (-1.05%) $0.84

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
390%
 
S&P 500 Returns
125%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/11/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.